The Global Burden of Aortic Stenosis

Progress in Cardiovascular Diseases

Volumn 56, Issue 6, 2014, Pages 565-571

  Thaden, Jeremy J ^a   Nkomo, Vuyisile T ^a   Enriquez Sarano, Maurice ^a  

^a MAYO CLINIC   (United States)

Author keywords

Aortic stenosis; Aortic valve replacement; Prevalence

Indexed keywords

AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; ASYMPTOMATIC DISEASE; CALCIFICATION; DISEASE SEVERITY; HISTORY OF MEDICINE; HUMAN; PATHOPHYSIOLOGY; PREVALENCE; SURGICAL APPROACH; SURVIVAL; TREATMENT INDICATION; TREND STUDY;

AORTIC STENOSIS; AORTIC VALVE REPLACEMENT; PREVALENCE;

AGE FACTORS; ANIMALS; AORTIC VALVE; AORTIC VALVE STENOSIS; CALCINOSIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PATIENT SELECTION; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; WORLD HEALTH;

EID: 84900013609     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2014.02.006     Document Type: Article

References (69)

1. Go A.S., Mozaffarian D., Roger V.L., et al. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013, 1:e6-e245.
2. Roberts W.C., Ko J.M. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 2005, 7:920-925.
3. Boon A., Cheriex E., Lodder J., et al. Cardiac valve calcification: characteristics of patients with calcification of the mitral annulus or aortic valve. Heart 1997, 5:472-474.
4. Stewart B.F., Siscovick D., Lind B.K., et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997, 3:630-634.
5. Bella J.N., Tang W., Kraja A., et al. Genome-wide linkage mapping for valve calcification susceptibility loci in hypertensive sibships: the Hypertension Genetic Epidemiology Network Study. Hypertension 2007, 3:453-460.
6. Thanassoulis G., Campbell C.Y., Owens D.S., et al. Genetic associations with valvular calcification and aortic stenosis. N Engl J Med 2013, 6:503-512.
7. Otto C.M., Kuusisto J., Reichenbach D.D., et al. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994, 2:844-853.
8. Watson K.E., Bostrom K., Ravindranath R., et al. TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest 1994, 5:2106-2113.
9. Mohler E.R., Gannon F., Reynolds C., et al. Bone formation and inflammation in cardiac valves. Circulation 2001, 11:1522-1528.
10. Miller J.D., Chu Y., Brooks R.M., et al. Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans. J Am Coll Cardiol 2008, 10:843-850.
11. Thubrikar M.J., Aouad J., Nolan S.P. Patterns of calcific deposits in operatively excised stenotic or purely regurgitant aortic valves and their relation to mechanical stress. Am J Cardiol 1986, 3:304-308.
12. Rajamannan N.M., Subramaniam M., Springett M., et al. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation 2002, 22:2660-2665.
13. Bellamy M.F., Pellikka P.A., Klarich K.W., et al. Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community. J Am Coll Cardiol 2002, 10:1723-1730.
14. Rosenhek R., Rader F., Loho N., et al. Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis. Circulation 2004, 10:1291-1295.
15. Cowell S.J., Newby D.E., Prescott R.J., et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005, 23:2389-2397.
16. Rossebo A.B., Pedersen T.R., Boman K., et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 2008, 13:1343-1356.
17. Nkomo V.T., Gardin J.M., Skelton T.N., et al. Burden of valvular heart diseases: a population-based study. Lancet 2006, 9540:1005-1011.
18. Iung B., Baron G., Butchart E.G., et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003, 13:1231-1243.
19. Sliwa K., Carrington M., Mayosi B.M., et al. Incidence and characteristics of newly diagnosed rheumatic heart disease in urban African adults: insights from the heart of Soweto study. Eur Heart J 2010, 6:719-727.
20. Osnabrugge R.L., Mylotte D., Head S.J., et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol 2013, 11:1002-1012.
21. Mylotte D., Osnabrugge R.L., Windecker S., et al. Transcatheter aortic valve replacement in Europe: adoption trends and factors influencing device utilization. J Am Coll Cardiol 2013, 3:210-219.
22. UN World population prospects: the 2010 revision 2011, 1-503.
23. Bonow R.O., Carabello B.A., Chatterjee K., et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008, 13:e1-e142.
24. Vahanian A., Alfieri O., Andreotti F., et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg 2012, 4:S1-S44.
25. Roger V.L., Tajik A.J., Bailey K.R., et al. Progression of aortic stenosis in adults: new appraisal using Doppler echocardiography. Am Heart J 1990, 2(Pt 1):331-338.
26. Brener S.J., Duffy C.I., Thomas J.D., et al. Progression of aortic stenosis in 394 patients: relation to changes in myocardial and mitral valve dysfunction. J Am Coll Cardiol 1995, 2:305-310.
27. Otto C.M., Burwash I.G., Legget M.E., et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation 1997, 9:2262-2270.
28. Nassimiha D., Aronow W.S., Ahn C., et al. Rate of progression of valvular aortic stenosis in patients>or=60years of age. Am J Cardiol 2001, 6:807-809. [A809].
29. Palta S., Pai A.M., Gill K.S., et al. New insights into the progression of aortic stenosis: implications for secondary prevention. Circulation 2000, 21:2497-2502.
30. Peter M., Hoffmann A., Parker C., et al. Progression of aortic stenosis. Role of age and concomitant coronary artery disease. Chest 1993, 6:1715-1719.
31. Briand M., Lemieux I., Dumesnil J.G., et al. Metabolic syndrome negatively influences disease progression and prognosis in aortic stenosis. J Am Coll Cardiol 2006, 11:2229-2236.
32. Kearney L.G., Ord M., Buxton B.F., et al. Progression of aortic stenosis in elderly patients over long-term follow up. Int J Cardiol 2013, 4:1226-1231.
33. Rosenhek R., Binder T., Porenta G., et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000, 9:611-617.
34. Dellgren G., Eriksson M.J., Blange I., et al. Angiotensin-converting enzyme gene polymorphism influences degree of left ventricular hypertrophy and its regression in patients undergoing operation for aortic stenosis. Am J Cardiol 1999, 8:909-913.
35. Wong K.K., Summers K.M., Burstow D.J., et al. Genetic variants of proteins from the renin angiotensin system are associated with pressure load cardiac hypertrophy. Clin Exp Pharmacol Physiol 1996, 6-7:587-590.
36. Ortlepp J.R., Breithardt O., Ohme F., et al. Lack of association among five genetic polymorphisms of the renin-angiotensin system and cardiac hypertrophy in patients with aortic stenosis. Am Heart J 2001, 4:671-676.
37. Ross J., Braunwald E. Aortic stenosis. Circulation 1968, (1 Suppl):61-67.
38. Pellikka P.A., Nishimura R.A., Bailey K.R., et al. The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis. J Am Coll Cardiol 1990, 5:1012-1017.
39. Pellikka P.A., Sarano M.E., Nishimura R.A., et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 2005, 24:3290-3295.
40. Malouf J., Le Tourneau T., Pellikka P., et al. Aortic valve stenosis in community medical practice: determinants of outcome and implications for aortic valve replacement. J Thorac Cardiovasc Surg 2012, 6:1421-1427.
41. Rosenhek R., Klaar U., Schemper M., et al. Mild and moderate aortic stenosis. Natural history and risk stratification by echocardiography. Eur Heart J 2004, 3:199-205.
42. Horstkotte D., Loogen F. The natural history of aortic valve stenosis. Eur Heart J 1988, 57-64.
43. Gohlke-Barwolf C., Minners J., Jander N., et al. Natural history of mild and of moderate aortic stenosis-new insights from a large prospective European study. Curr Probl Cardiol 2013, 9:365-409.
44. Eleid M.F., Nishimura R.A., Borlaug B.A., et al. Invasive measures of afterload in low gradient severe aortic stenosis with preserved ejection fraction. Circ Heart Fail 2013, 4:703-710.
45. Michelena H.I., Margaryan E., Miller F.A., et al. Inconsistent echocardiographic grading of aortic stenosis: is the left ventricular outflow tract important?. Heart 2013, 13:921-931.
46. Monin J.L., Quere J.P., Monchi M., et al. Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation 2003, 3:319-324.
47. Nishimura R.A., Grantham J.A., Connolly H.M., et al. Low-output, low-gradient aortic stenosis in patients with depressed left ventricular systolic function: the clinical utility of the dobutamine challenge in the catheterization laboratory. Circulation 2002, 7:809-813.
48. Tribouilloy C., Levy F., Rusinaru D., et al. Outcome after aortic valve replacement for low-flow/low-gradient aortic stenosis without contractile reserve on dobutamine stress echocardiography. J Am Coll Cardiol 2009, 20:1865-1873.
49. Quere J.P., Monin J.L., Levy F., et al. Influence of preoperative left ventricular contractile reserve on postoperative ejection fraction in low-gradient aortic stenosis. Circulation 2006, 14:1738-1744.
50. Clavel M.A., Dumesnil J.G., Capoulade R., et al. Outcome of patients with aortic stenosis, small valve area, and low-flow, low-gradient despite preserved left ventricular ejection fraction. J Am Coll Cardiol 2012, 14:1259-1267.
51. Eleid M.F., Sorajja P., Michelena H.I., et al. Flow-gradient patterns in severe aortic stenosis with preserved ejection fraction: clinical characteristics and predictors of survival. Circulation 2013, 16:1781-1789.
52. Hachicha Z., Dumesnil J.G., Bogaty P., et al. Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival. Circulation 2007, 22:2856-2864.
53. Herrmann S., Stork S., Niemann M., et al. Low-gradient aortic valve stenosis myocardial fibrosis and its influence on function and outcome. J Am Coll Cardiol 2011, 4:402-412.
54. Lancellotti P., Magne J., Donal E., et al. Clinical outcome in asymptomatic severe aortic stenosis: insights from the new proposed aortic stenosis grading classification. J Am Coll Cardiol 2012, 3:235-243.
55. Pibarot P., Dumesnil J.G. Low-flow, low-gradient aortic stenosis with normal and depressed left ventricular ejection fraction. J Am Coll Cardiol 2012, 19:1845-1853.
56. Aggarwal S.R., Clavel M.A., Messika-Zeitoun D., et al. Sex differences in aortic valve calcification measured by multidetector computed tomography in aortic stenosis. Circ Cardiovasc Imaging 2013, 1:40-47.
57. Bech-Hanssen O., Caidahl K., Wall B., et al. Influence of aortic valve replacement, prosthesis type, and size on functional outcome and ventricular mass in patients with aortic stenosis. J Thorac Cardiovasc Surg 1999, 1:57-65.
58. De Paulis R., Sommariva L., Colagrande L., et al. Regression of left ventricular hypertrophy after aortic valve replacement for aortic stenosis with different valve substitutes. J Thorac Cardiovasc Surg 1998, 4:590-598.
59. Lund O., Flo C., Jensen F.T., et al. Left ventricular systolic and diastolic function in aortic stenosis. Prognostic value after valve replacement and underlying mechanisms. Eur Heart J 1997, 12:1977-1987.
60. Lund O., Magnussen K., Knudsen M., et al. The potential for normal long term survival and morbidity rates after valve replacement for aortic stenosis. J Heart Valve Dis 1996, 3:258-267.
61. Morris J.J., Schaff H.V., Mullany C.J., et al. Determinants of survival and recovery of left ventricular function after aortic valve replacement. Ann Thorac Surg 1993, 1:22-29. [discussion 29-30].
62. Bach D.S., Siao D., Girard S.E., et al. Evaluation of patients with severe symptomatic aortic stenosis who do not undergo aortic valve replacement: the potential role of subjectively overestimated operative risk. Circ Cardiovasc Qual Outcomes 2009, 6:533-539.
63. Iung B., Cachier A., Baron G., et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery?. Eur Heart J 2005, 24:2714-2720.
64. Amato M.C., Moffa P.J., Werner K.E., et al. Treatment decision in asymptomatic aortic valve stenosis: role of exercise testing. Heart 2001, 4:381-386.
65. Gerber I.L., Stewart R.A., Legget M.E., et al. Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation 2003, 14:1884-1890.
66. Cohn L.H., Collins J.J., Rizzo R.J., et al. Twenty-year follow-up of the Hancock modified orifice porcine aortic valve. Ann Thorac Surg 1998, (6 Suppl):S30-S34.
67. David T.E., Armstrong S., Maganti M. Hancock II bioprosthesis for aortic valve replacement: the gold standard of bioprosthetic valves durability?. Ann Thorac Surg 2010, 3:775-781.
68. Suri R.M., Schaff H.V. Selection of aortic valve prostheses: contemporary reappraisal of mechanical versus biologic valve substitutes. Circulation 2013, 12:1372-1380.
69. Brown J.M., O'Brien S.M., Wu C., et al. Isolated aortic valve replacement in North America comprising 108,687 patients in 10years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg 2009, 1:82-90.